AstraZeneca admits that Covishield can cause blood clotting

pharma giant AstraZeneca admitted that its Covid vaccine Covishield can cause blood clotting in rare cases. The Telegraph (UK) revealed that the vaccine maker has said so in court documents. Developed by AstraZeneca and Oxford University during the COVID-19 pandemic, the vaccine was manufactured by Serum Institute of India and was administered all over in vaccine camps.